Daniel Loeb's position in Pfizer is currently worth $51.2 Million. That's 0.83% of their equity portfolio (27th largest holding). The first Pfizer trade was made in Q3 2005. Since then Daniel Loeb bought shares four more times and sold shares on one occasions. The stake costed the investor $34.9 Million, netting the investor a gain of 47% so far.